Tag: biosimilars
Planning for Patent Expiry: What Patients and Healthcare Systems Need to Do Now
12 Jan
|
14:12 PM
Patent expiry means cheaper drugs-but only if you're prepared. Learn how patients and healthcare systems can save money and avoid disruptions when brand-name drugs go generic.
read morerecent posts
Generic Competition Explained: How Second and Third Entrants Slash Drug Prices
Discover how additional generic drug manufacturers drive down costs. Learn why the second and third generic entrants are crucial for significant price reductions and why some drugs stay expensive.
Published ON: 1 Apr
Quality Control Testing: A Step-by-Step Guide to Manufacturing QA
Learn the essential steps of quality control testing in manufacturing, from raw material inspection and IPQC to ISO standards and CAPA procedures.
Published ON: 4 Apr